FDA Adverse Event Injury Summary report: N

FINELINE II

MDR report key: 1945759 · Received January 4, 2011

Report

Report Number
2124215-2010-20242
Event Type
Injury
Date Received
January 4, 2011
Date of Event
October 13, 2010
Report Date
January 7, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE LEAD HAS BEEN RETURNED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON COMPLETION OF ANALYSIS.

Additional Manufacturer Narrative · 1

THE LEAD IS EXPECTED TO BE RETURNED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON RETURN AND COMPLETION OF ANALYSIS.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THE LEAD WAS ANALYZED. VISUAL INSPECTION NOTED DRIED BODY FLUID IN THE LEAD LUMEN AND TISSUE IN THE HELIX. ELECTRICAL AND PRESSURE TESTS WERE PERFORMED. THE LEAD WAS ELECTRICALLY DISCONTINUOUS AND A HOLE IN THE INSULATION WAS NOTED APPROXIMATELY 30 CM FROM THE TERMINAL PIN. X-RAYS CONFIRMED THE LEAD CONDUCTOR HAD FRACTURED IN SEVERAL PLACES AT APPROXIMATELY 27 AND 30 CM FROM THE TERMINAL PIN. ANALYSIS NOTED INSULATION MARKS CONSISTENT WITH THE REPORTED FIGURE-EIGHT BEND IN THE LEAD. ANALYSIS CONCLUDED THE FRACTURE WAS LIKELY A RESULT OF THE FIGURE-EIGHT BEND AND FIRST RIB CLAVICULAR CRUSH.

Description of Event or Problem · 1

--

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT, DURING A ROUTINE FOLLOW-UP APPOINTMENT, IT WAS NOTED THIS LEAD HAD A PACING IMPEDANCE MEASUREMENT GREATER THAN 2500 OHMS. THE PATIENT WAS HOSPITALIZED. AN X-RAY WAS PERFORMED, AND A PORTION OF THE LEAD WAS SHAPED IN A FIGURE-EIGHT, WITH A CRACK NOTED ON ONE OF THE LOOPS. THE LEAD WAS EXPLANTED AND REPLACED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4471

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention